We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Orig3N, LabCorp Collaborate on iPSC
News

Orig3N, LabCorp Collaborate on iPSC

Orig3N, LabCorp Collaborate on iPSC
News

Orig3N, LabCorp Collaborate on iPSC

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Orig3N, LabCorp Collaborate on iPSC"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Orig3N have announced that Laboratory Corporation of America has invested in the firm and will provide storage for Orig3N's induced pluripotent stem cell repository. 

The Boston-based biotech firm did not disclose the amount of LabCorp's investment. LabCorp will provide storage for the iPSC repository called LifeCapsule in its biorepository facilities and will perform genetic testing on the stored cells. The partnership will increase LifeCapsule's utility and create a well-characterized library of specimens, Orig3N said. 

The company is developing a disease-modeling platform targeting rare genetically inherited diseases. In February, it raised $3.1 million in a private financing round.

Advertisement